Clinical trial Recruiting at 6 sites Observational Ages 18 and up

Blood test for early detection of colorectal cancer and adenomas

Official title: A Liquid Biopsy Assay For The Non-Invasive Early Detection of Advanced Adenomas and Colorectal Cancer

Run by City of Hope Medical Center · NCT06342440 · Data updated 2026-11-12

This study is testing a new blood test to see if it can help find early signs of colorectal cancer and adenomas in people who are already scheduled for a colonoscopy.

More Colorectal Cancer trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorCity of Hope Medical Center
Academic / other
Locations6 sites (Monrovia, California and 5 other locations)
StatusRecruiting
StartedMarch 15, 2020
Main results expectedJune 18, 2028
Study endsJune 18, 2028
Registry record updatedJuly 7, 2026
Trial IDNCT06342440 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who have undergone a colonoscopy and are at risk for colorectal cancer or adenomas.

Probably not a fit

Patients with hereditary colorectal cancer syndromes or inflammatory bowel diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop a highly sensitive and cost-effective blood assay for the early detection of colorectal adenomas and cancer using advanced machine learning techniques and biological analyses. Colorectal cancer is a major health concern, and traditional screening methods often miss precursor lesions like adenomas. The proposed liquid biopsy test seeks to provide a non-invasive alternative that can detect both conditions from a single blood draw, thereby improving patient compliance and resource allocation. Participants will have undergone a colonoscopy, and blood samples will be collected prior to any curative treatment.

Why it matters

Potential benefit: If successful, this test could significantly improve early detection rates of colorectal cancer and adenomas, potentially reducing mortality associated with these conditions.

How similar studies have gone: Other studies have shown promise in using liquid biopsies for cancer detection, but this specific approach targeting colorectal adenomas and cancer is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All individuals included in the study need to have had a colonoscopy at the time of blood sampling.
* Received standard diagnostic and staging (as necessary) procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
* Received standard pathological and endoscopic diagnosis and assessment for cohort assignment.

Exclusion Criteria:

* Hereditary colorectal cancer syndromes (identified through genetic testing).
* Inflammatory bowel diseases.
* Lack of written informed consent.

Where it's running

  • City of Hope Medical Center
    Monrovia, California, United States
    Recruiting
  • University of California San Diego
    San Diego, California, United States
    Recruiting
  • The First Affiliated Hospital of Dalian Medical University
    Dalian, China
    Recruiting
  • IRCCS San Raffaele
    Milan, Italy
    Recruiting
  • Mie University
    Mie, Japan
    Recruiting
  • Barcelona University
    Barcelona, Spain
    Recruiting

Study contacts

  • Principal investigator: Ajay Goel, PhD — City of Hope Medical Center
  • Study coordinator: Ajay Goel, PhD
  • Email: AJGOEL@COH.ORG
  • Phone: 6262183452

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.